Computerized alerts could improve physicians' prescribing practices

September 05, 2005

A computer monitoring system could significantly improve doctors' prescribing habits, according to a study published in the forthcoming issue of the open-access journal PLoS Medicine.

The monitoring system was designed to reduce the unwanted side affects of drug treatment, otherwise known as adverse drug events (ADEs), by alerting doctors to the potential dangers of a drug to a particular patient. In the United States alone, more than three quarters of a million people are injured or killed as a result of ADEs every year.

Andrew Steele and colleagues designed and tested a system that alerts doctors when medication is ordered for an outpatient clinic in a hospital in Denver, Colorado. The prescriber is alerted when one of five possible ADEs is likely to occur, or when the patient requires further tests to establish whether or not the drug is likely to be safe. The researchers tested the system's effectiveness by examining how doctors acted when alerted and what they did when the system was switched off. They found that it was possible to alter the behaviour of prescribers by alerting them to possible problems; in particular, prescribers were more likely to stop a prescription or to order more tests when they were alerted.

The benefits of a successful computer monitoring system could be great. Reducing ADEs could have a dramatic impact on hospital budgets because they can cost a hospital as much as US$5.6 million per year after litigation. Most importantly the benefit would be felt by patients, who spend on average between eight and twelve days longer in the hospital if affected by an ADE.
-end-
Citation: Steele AW, Eisert S, Witter J, Lyons P, Jones MA, et al. (2005) The effect of automated alerts on provider ordering behavior in an outpatient setting. PLoS Med 2(9): e255.

CONTACT:
Andrew Steele
Denver Health Information Services
MC 1932
660 Bannock Street
Denver, CO USA
+1-303-436-4812
+1-303-436-5952 (fax)
asteele@dhha.org

PLEASE MENTION PLoS Medicine (www.plosmedicine.org) AS THE SOURCE FOR THESE ARTICLES. THANK YOU.

All works published in PLoS Medicine are open access. Everything is immediately available without cost to anyone, anywhere to read, download, redistribute, include in databases, and otherwise use¡Xsubject only to the condition that the original authorship is properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.

PLOS

Related Drug Articles from Brightsurf:

New drug that can prevent the drug resistance and adverse effects
A research team in Korea is garnering attention for having developed an anticancer drug that could potentially prevent drug resistance.

Potent drug supply drop, not domestic drug policies, likely behind 2018 OD death downturn
The slight decline in drug overdose deaths in 2018 coincides with Chinese regulations on the powerful opioid carfentanil, rather than the result of domestic U.S. efforts to curb the epidemic, a new analysis reveals.

Old drug standards delay new drug approvals
The more information the FDA has about existing drugs, the longer it takes to OK new ones for the same conditions.

What drug companies spend to bring a new drug to market
Researchers estimated the cost to bring 63 new drugs or biologics to market between 2009 and 2018 using publicly available data on research and development expenditures for these medicines.

New flu drug drives drug resistance in influenza viruses
University of Wisconsin-Madison researchers examined the effects of baloxavir treatment on influenza virus samples collected from patients before and after treatment.

Cause of drug resistance in a drug resistance in intestinal tumors identified
Researchers clarify mechanisms that allow hard-to-treat cancers to develop, and have identified strategies that could lead to new therapies.

AI could offer warnings about serious side effects of drug-drug interactions
Researchers at Penn State have developed a machine learning system that may be able to warn doctors and patients about possible negative side effects that might occur when drugs are mixed.

Charcoal-based drug delivery system improves efficacy of common herpes drug
A study led by researchers from the University of Illinois at Chicago has found that combining acyclovir -- a commonly prescribed topical herpes medication -- with particles of activated carbon improves efficacy of the drug.

Candida auris is a new drug-resistant fungus emerging globally and in the US early detection is key to controlling spread of deadly drug-resistant fungus
Early identification of Candida auris, a potentially deadly fungus that causes bloodstream and intra-abdominal infections, is the key to controlling its spread.

Arming drug hunters, chemists design new reaction for drug discovery
Colorado State University organic chemists have forged a powerful new tool for drug hunters -- a simple, elegantly designed chemical reaction that could fling open an underexplored wing of biologically relevant chemistry.

Read More: Drug News and Drug Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.